BioVentrix Revivent TC™ System Clinical Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2027

Conditions
Ventricular Dysfunction, Left
Interventions
DEVICE

Revivent TC

Treatment of LV scar

Trial Locations (30)

10029

Mount Sinai Hospital, New York

10065

New York Presbyterian Hospital, New York

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

17101

UPMC Pinnacle, Harrisburg

19104

Hospital of the University of Pennsylvania, Philadelphia

22601

Winchester Medical Center, Winchester

27157

Wake Forest Baptist Hospital, Winston-Salem

29425

Medical University of South Carolina, Charleston

30060

WellStar Health System, Marietta

30308

Emory University Hospital Midtown, Atlanta

33176

Baptist Hospital of Maimi, Miami

44195

Cleveland Clinic, Cleveland

55455

University of Minnesota Medical Center, Minneapolis

62781

Memorial Medical Center, Springfield

64111

Saint Luke's Hospital of Kansas City, Kansas City

70360

Terrebonne General Medical Center, Houma

73120

Oklahoma Heart Hospital, Oklahoma City

77030

CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston

Houston Methodist Hospital, Houston

85004

University of Arizona College of Medicine - Phoenix Banner University Medicine Heart Institute, Phoenix

90024

Ronald Regan UCLA Medical Center, Los Angeles

91360

Los Robles Hospital & Medical Center, Thousand Oaks

94143

University of California, San Francisco, San Francisco

48109-5856

University of Michigan, Ann Arbor

07601

Hackensack University Medical Center, Hackensack

150 30

Nemocnice Na Homolce, Prague

151 23

Hygeia Hospital, Athens

Unknown

Interbalkan Medical Center, Thessaloniki

CB23 3RE

Papworth Hospital NHS Foundation Trust, Cambridge

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioVentrix

INDUSTRY